Signaling T-cell survival and death by IL-2 and IL-15

被引:45
作者
Zambricki, E
Shigeoka, A
Kishimoto, H
Sprent, J
Burakoff, S
Carpenter, C
Milford, E
McKay, D [1 ]
机构
[1] Scripps Res Inst, Dept Immunol, La Jolla, CA 92037 USA
[2] NYU, Sch Med, Skirball Inst Biomol Med, Dept Med, New York, NY USA
[3] NYU, Sch Med, Skirball Inst Biomol Med, Dept Pediat, New York, NY USA
[4] NYU, Sch Med, Skirball Inst Biomol Med, Dept Pathol, New York, NY USA
[5] Harvard Univ, Brigham & Womens Hosp, Sch Med, Dept Med,Div Nephrol, Boston, MA 02115 USA
关键词
cytokines; cytokine receptors; signal transduction; T cells; transplantation;
D O I
10.1111/j.1600-6143.2005.01075.x
中图分类号
R61 [外科手术学];
学科分类号
摘要
Interleukin 2 (IL-2) and interleukin 15 (IL-15) bind to common T-cell surface receptors comprised of unique alpha (IL-2R alpha or IL-15R alpha) and shared beta/gamma chain subunits. Ligation of this receptor by IL-2 can lead to apoptosis whereas IL-15 ligation favors cell survival. Our study examined intra-cellular signaling events associated with IL-2- and IL-15-induced apoptosis and survival in human T cells. We found IL-2 and IL-15 could both induce apoptosis and survival; the outcome depended on cytokine concentration. No qualitative differences in Jak/Stat, Ras/MAPK or PI3K/AKT signaling were seen over a wide range of IL-2 and IL-15 concentrations. These findings suggest that, like T-cell receptor signaling, IL-2R beta/gamma chain signaling is regulated, or "tuned," by the concentration of cytokine.
引用
收藏
页码:2623 / 2631
页数:9
相关论文
共 50 条
  • [41] A soluble single-chain T-cell receptor IL-2 fusion protein retains MHC-restricted peptide specificity and IL-2 bioactivity
    Kimberlyn F. Card
    Shari A. Price-Schiavi
    Bai Liu
    Elizabeth Thomson
    Esperanza Nieves
    Heather Belmont
    Janette Builes
    Jin-an Jiao
    Javier Hernandez
    Jon Weidanz
    Linda Sherman
    John L. Francis
    Ali Amirkhosravi
    Hing C. Wong
    Cancer Immunology, Immunotherapy, 2004, 53 : 345 - 357
  • [42] Effects of Immunoregulatory Cytokines (IL-2, IL-7, and IL-15) on Expression of Gfi1 and U2afll4 Genes in T Cells at Different Stages of Differentiation
    Sokhonevich, N. A.
    Yurova, K. A.
    Gutsol, A. A.
    Khaziakhmatova, O. G.
    Mazunin, I. O.
    Litvinova, L. S.
    BULLETIN OF EXPERIMENTAL BIOLOGY AND MEDICINE, 2015, 159 (02) : 236 - 239
  • [43] The CIK cells stimulated with combination of IL-2 and IL-15 provide an improved cytotoxic capacity against human lung adenocarcinoma
    Wei, Chuanyu
    Wang, Wenju
    Pang, Wei
    Meng, Mingyao
    Jiang, Lihong
    Xue, Sha
    Xie, Yanhua
    Li, Ruhong
    Hou, Zongliu
    TUMOR BIOLOGY, 2014, 35 (03) : 1997 - 2007
  • [44] Effects of Immunoregulatory Cytokines (IL-2, IL-7, and IL-15) on Expression of Gfi1 and U2afll4 Genes in T Cells at Different Stages of Differentiation
    N. A. Sokhonevich
    K. A. Yurova
    A. A. Gutsol
    O. G. Khaziakhmatova
    I. O. Mazunin
    L. S. Litvinova
    Bulletin of Experimental Biology and Medicine, 2015, 159 : 236 - 239
  • [45] Analysis of IL-2, IL-4 and their receptors in clonally-related cell lines derived from a patient with a progressive cutaneous T-cell lymphoproliferative disorder
    Wasik, MA
    Seldin, DC
    Butmarc, JR
    Gertz, R
    Marti, R
    Maslinski, W
    Kadin, ME
    LEUKEMIA & LYMPHOMA, 1996, 23 (1-2) : 125 - &
  • [46] Expression of IL-15 and IL-15 receptor isoforms in select structures of human fetal brain
    Kurowska, M
    Rudnicka, W
    Maslinska, D
    Maslinski, W
    NEUROENDOCRINE IMMUNE BASIS OF THE RHEUMATIC DISEASES II, PROCEEDINGS, 2002, 966 : 441 - 445
  • [47] IFN-γ is only partially restored by co-stimulation with IL-12, IL-2, IL-15, IL-18 or engagement of CD28
    Jung, T
    Witzak, K
    Dieckhoff, K
    Zachmann, K
    Heidrich, S
    Aversa, G
    Neumann, C
    CLINICAL AND EXPERIMENTAL ALLERGY, 1999, 29 (02) : 207 - 216
  • [48] Can IL-15 superagonist ALTer GVL?
    Soiffer, Robert J.
    BLOOD, 2018, 131 (23) : 2511 - 2512
  • [49] A soluble single-chain T-cell receptor IL-2 fusion protein retains MHC-restricted peptide specificity and IL-2 bioactivity
    Card, KF
    Price-Schiavi, SA
    Liu, B
    Thomson, E
    Nieves, E
    Belmont, H
    Builes, J
    Jiao, JA
    Hernandez, J
    Weidanz, J
    Sherman, L
    Francis, JL
    Amirkhosravi, A
    Wong, HC
    CANCER IMMUNOLOGY IMMUNOTHERAPY, 2004, 53 (04) : 345 - 357
  • [50] IL-15Rα membrane anchorage in either cis or trans is required for stabilization of IL-15 and optimal signaling
    Quemener, Agnes
    Morisseau, Sebastien
    Sousa, Rui P.
    Trillet, Kilian
    Maillasson, Mike
    Leray, Isabelle
    Jacques, Yannick
    Dion, Johann
    Barbieux, Isabelle
    Frutoso, Marie
    Laurent, Adele D.
    Le Questel, Jean-Yves
    Mortier, Erwan
    JOURNAL OF CELL SCIENCE, 2020, 133 (05)